MARC SCIENTIFIC ADVISORY BOARD
The MARC has assembled a group of distinguished scientists in closely related fields to serve as our scientific advisory board (SAB). The group meets with our investigators approximately once a year in Portland, reviews the annual written progress reports we submit to our funding agency, and evaluates each year's pilot-project proposals to give input on their merit. In addition, SAB members may be called on to advise individual members of the MARC as specific issues arise.
Our advisors:
Dr. Marshall's work includes research on brain recovery following injury, cellular factors contributing to neurodegeneration, organization of basal ganglia motor systems, and computer-assisted quantitative localization of transmitter receptors in the central nervous system.
 Martin Paulus, M.D.
Professor, Department of Psychiatry
University of California at San Diego
Dr. Paulus' work focuses on how decision-making dysfunctions contribute to the transition from casual use of drugs to dependence and how these dysfunctions contribute to relapse in individuals with stimulant dependence.
Dr. Robinson's research interests include neuropsychopharmacology; neurobiology of addiction; long-term effects of psychomotor stimulant drugs and stress on brain and behavior; neural adaptations to brain damage; and brain dopamine systems.
 Bryan Yamamoto, Ph.D.
Professor and Chair, Department of Neurosciences
University of Toledo
Dr. Yamamoto's primary research interests lie in neuropharmacology, neurodegeneration, and the neurotoxicity of the amphetamines. The overall hypothesis is that the amphetamines, through the enhanced release of dopamine and glutamate, promote excitotoxicity, free-radical mediated oxidative stress, and produce a compromised bioenergetic state that damage dopamine and 5HT neurons.
 John Williams, Ph.D.
Vollum Institute for Advanced Biomedical Research
Dr. Williams is an authority on the responses of neuronal systems to abused drugs, measured using electrophysiological methods. He and his colleagues investigate the early events that lead to the development of tolerance to opioids.
Dr. Zahniser researches the interactions of abused drugs with aminergic transporters and the disposition of neurotransmitters.
|
